Moreover, the contribution of released factors by SAT on CD11B transcription might suggest a systemic effect which could be modulated by dapagliflozin and protect against the subjacent inflammation to obesity and cardiovascular disease. This evidence concerns the gene ITGAM and cardiovascular disorder.